2022
Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia
Ouellet GM, O'Leary JR, Leggett CG, Skinner J, Tinetti ME, Cohen AB. Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia. Journal Of The American Geriatrics Society 2022, 71: 561-568. PMID: 36310367, PMCID: PMC9957933, DOI: 10.1111/jgs.18108.Peer-Reviewed Original ResearchConceptsNursing home residentsAtrial fibrillationAdvanced dementiaHome residentsStroke riskLong-stay nursing home residentsMedicare Part D claimsDementia-related mortalityGuideline-recommended thresholdHarms of anticoagulationRetrospective cohort studyMultivariable survival analysisValvular heart diseaseRisk of deathPart D claimsMonths of lifeMinimum Data SetAnticoagulant discontinuationAnticoagulated individualsMean CHAVASc scoreCause mortalityMultivariable adjustmentOral anticoagulantsCohort study
2020
Guardianship and End‐of‐Life Care for Veterans with Dementia in Nursing Homes
Cohen AB, Han L, OʼLeary JR, Fried TR. Guardianship and End‐of‐Life Care for Veterans with Dementia in Nursing Homes. Journal Of The American Geriatrics Society 2020, 69: 342-348. PMID: 33170957, PMCID: PMC7902349, DOI: 10.1111/jgs.16900.Peer-Reviewed Original ResearchConceptsDays of lifeHospital deathHigh-intensity treatmentMechanical ventilationTube placementHome residentsCardiopulmonary resuscitationNursing homesIntensive care unit admissionMinimum Data Set assessmentsCare unit admissionRetrospective cohort studyNursing home residentsHigh-intensity endMore nursing homesUnit admissionICU admissionCohort studySecondary outcomesPrimary outcomeHospital transferLife hospitalizationsSevere dementiaLife careDementia severity
2019
End‐of‐Life Decision Making and Treatment for Patients with Professional Guardians
Cohen AB, Benjamin AZ, Fried TR. End‐of‐Life Decision Making and Treatment for Patients with Professional Guardians. Journal Of The American Geriatrics Society 2019, 67: 2161-2166. PMID: 31301189, PMCID: PMC6800801, DOI: 10.1111/jgs.16072.Peer-Reviewed Original ResearchConceptsHigh-intensity treatmentPatient preferencesHospice careVeterans Affairs Connecticut Healthcare SystemUnderwent cardiopulmonary resuscitationRetrospective cohort studyIntensive care unitLast monthAdvance care planningLife decisionsDecedent patientsLife decision makingChart reviewCohort studyCare unitTreatment outcomesCardiopulmonary resuscitationOutpatient facilitiesLife careCare planningVA recordsVA facilitiesProfessional guardiansPatientsOlder adults
2011
Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
Satlin MJ, Kubin CJ, Blumenthal JS, Cohen AB, Furuya EY, Wilson SJ, Jenkins SG, Calfee DP. Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine. Antimicrobial Agents And Chemotherapy 2011, 55: 5893-5899. PMID: 21968368, PMCID: PMC3232750, DOI: 10.1128/aac.00387-11.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAminoglycosidesAnti-Bacterial AgentsCarbapenemsCohort StudiesDrug Resistance, BacterialFemaleHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMiddle AgedMinocyclinePolymyxin BRetrospective StudiesTigecyclineTreatment OutcomeUrinary Tract InfectionsUrineYoung AdultConceptsCarbapenem-resistant Klebsiella pneumoniaePolymyxin BCRKP bacteriuriaMicrobiologic clearanceUntreated cohortHealth care-associated urinary tract infectionsClearance rateKlebsiella pneumoniaeRetrospective cohort studyUrinary tract infectionNew York Presbyterian HospitalCohort studyTract infectionsUrine cultureAntimicrobial therapyAppropriate followCommon causeActive agentsMultiple active agentsTigecyclineComparative effectivenessMultivariate analysisCohortGram-negative activityAminoglycosides